MedPath

KAMEDIS LTD.

🇮🇱Israel
Ownership
-
Employees
-
Market Cap
-
Website

Safety and Efficacy of SEBORRHEAMEDIS Face Cream in Patients With Seborrheic Dermatitis

Not Applicable
Completed
Conditions
Seborrheic Dermatitis
Interventions
Device: SEBORRHEAMEDIS Face Cream
First Posted Date
2016-01-14
Last Posted Date
2016-01-14
Lead Sponsor
Kamedis Ltd.
Target Recruit Count
30
Registration Number
NCT02656368

Clinical Study to Evaluate Safety and Efficacy of KAM1403 Gel to Treat Radiation Dermatitis

Phase 2
Conditions
Radiation Dermatitis
Interventions
Device: KAM1403 Gel
Device: aloevera gel
First Posted Date
2014-01-31
Last Posted Date
2014-01-31
Lead Sponsor
Kamedis Ltd.
Target Recruit Count
60
Registration Number
NCT02051907
Locations
🇮🇱

Sourasky Medical Center, Tel Aviv, Israel

Efficacy of KAM2904 Face Cream and KAM3008 Body Lotion Treatment in Children With Atopic Dermatitis (AD)

Phase 4
Conditions
Atopic Dermatitis
Interventions
Device: KAM2904 Face Cream
Other: petrolatum-based moisturizer
Device: KAM3008 Body Lotion
First Posted Date
2013-02-01
Last Posted Date
2014-01-30
Lead Sponsor
Kamedis Ltd.
Target Recruit Count
56
Registration Number
NCT01781663
Locations
🇪🇸

Fundación Teknon, Barcelona, Spain

© Copyright 2025. All Rights Reserved by MedPath